KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.90

Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial.

Umesh Mahantshetty, Shirley Lewis, Reena Engineer, Jamema Swamidas, Supriya Chopra, Lavanya Gurram, Rajesh Kinhikar, Deepak Deshpande, Christian Kirisits, Shyamkishore Shrivastava

Brachytherapy 20(6) 1146-1155

PMID34598883
PMCID-
DOI10.1016/j.brachy.2021.08.012
发表日期2021-10-02
入排依据:The record describes a Phase III randomized trial in cervical cancer (oncology, human) with primary time-to-event efficacy endpoints (DFS, OS). However, the intervention is intracavitary brachytherapy (a radiotherapy technique), not a drug-containing intervention. Therefore, it does not meet the drug intervention criterion.
摘要

摘要

PURPOSE: Intracavitary brachytherapy using High-Dose-Rate (HDR) and Low-dose-rate (LDR) in cervical cancer has been utilized. We report the long-term final results of a large randomized trial in terms of toxicities and efficacy. METHODS AND MATERIALS: Between 1996 to 2005, 816 patients were randomized to LDR (n = 441 patients) or HDR brachytherapy (n = 369 patients) stratified by FIGO Stage grouping. Patients with Stage I-II received external irradiation of 40 Gy in 20 fractions (with midline block (MLB)) followed by either 2 LDR Intracavitary applications of 30 Gy to point A (2-3 weeks apart) or 5 HDR Intracavitary applications of 7 Gy to point A once weekly. Patients with Stage III received 50 Gy in 25 fractions (with MLB after 40 Gy) followed by either one application of LDR 30 Gy to point A or three applications of HDR 7 Gy to point A once weekly. RESULTS: With a median follow-up was 64 months (interquartile range [IQR]: 21 - 111), moderate to severe rectal and bladder complications were higher in LDR arm as compared to HDR arm (9.7% vs. 3.6%; p = 0.02) and (10.5% vs. 5.5%; p = 0.06) for Stage I-II. No difference in rectal or bladder complications for Stage III patients. Disease free and overall survivals were similar in both the arms for all stages. CONCLUSIONS: HDR intracavitary brachytherapy with 7 Gy per fraction weekly is superior to LDR in terms of late rectal and bladder complications. Local control rates and survivals are similar irrespective of stages.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。